Overview
Global Medical REIT Q3 rental revenue grows 8.4% yr/yr, driven by acquisitions
Company reports Q3 net loss due to $6.3 mln impairment charge on Aurora facility
Global Medical REIT establishes $50 mln share repurchase program, no shares repurchased yet
Outlook
Company narrows full-year 2025 AFFO guidance to $4.50-$4.60 per share and unit
Company assumes no additional acquisitions or dispositions for 2025 guidance
Company expects no further equity or debt issuances beyond normal revolver activity
Result Drivers
ACQUISITIONS DRIVE REVENUE - Rental revenue increased by 8.4% yr/yr, primarily due to acquisitions completed after September 2024
IMPAIRMENT CHARGE - $6.3 mln impairment charge on Aurora facility contributed to net loss
DISPOSITIONS - Completed two property sales, generating $3.8 mln in proceeds
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Rental Revenue
$37.03 mln
Q3 Net Income
-$5.05 mln
Q3 Adjusted FFO
$16.24 mln
Q3 FFO
$14.53 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy"
Wall Street's median 12-month price target for Global Medical REIT Inc is $41.75, about 27% above its November 3 closing price of $30.46
The stock recently traded at 150 times the next 12-month earnings vs. a P/E of 50 three months ago
Press Release: ID:nBwb1hbBya
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)